123 related articles for article (PubMed ID: 33644942)
1. Editorial Comment to Prognostic significance of tertiary Gleason pattern in the contemporary era of Gleason grade grouping: A narrative review.
Tsuzuki T
Int J Urol; 2021 Jun; 28(6):621-622. PubMed ID: 33644942
[No Abstract] [Full Text] [Related]
2. Prognostic significance of tertiary Gleason pattern in the contemporary era of Gleason grade grouping: A narrative review.
Taguchi S; Morikawa T; Shibahara J; Fukuhara H
Int J Urol; 2021 Jun; 28(6):614-621. PubMed ID: 33580599
[TBL] [Abstract][Full Text] [Related]
3. Quantification of the individual risk of each Gleason pattern, including tertiary Gleason pattern 5, after radical prostatectomy: development of the modified Gleason grade grouping (mGGG) model.
Taguchi S; Uemura Y; Fujimura T; Morikawa T; Naito A; Kawai T; Suzuki M; Kume H; Fukuhara H
BMC Cancer; 2020 May; 20(1):371. PubMed ID: 32357849
[TBL] [Abstract][Full Text] [Related]
4. Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
Epstein JI; Amin MB; Reuter VE; Humphrey PA
Am J Surg Pathol; 2017 Apr; 41(4):e1-e7. PubMed ID: 28177964
[TBL] [Abstract][Full Text] [Related]
5. A tertiary Gleason pattern in the prostatectomy specimen and its association with adverse outcome after radical prostatectomy.
Adam M; Hannah A; Budäus L; Steuber T; Salomon G; Michl U; Haese A; Fisch M; Wittmer C; Steurer S; Minner S; Heinzer H; Huland H; Graefen M; Sauter G; Schlomm T; Isbarn H
J Urol; 2014 Jul; 192(1):97-101. PubMed ID: 24518778
[TBL] [Abstract][Full Text] [Related]
6. Integrating Tertiary Gleason 5 Patterns into Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens.
Sauter G; Clauditz T; Steurer S; Wittmer C; Büscheck F; Krech T; Lutz F; Lennartz M; Harms L; Lawrenz L; Möller-Koop C; Simon R; Jacobsen F; Wilczak W; Minner S; Tsourlakis MC; Chirico V; Weidemann S; Haese A; Steuber T; Salomon G; Matiu M; Vettorazzi E; Michl U; Budäus L; Tilki D; Thederan I; Pehrke D; Beyer B; Fraune C; Göbel C; Heinrich M; Juhnke M; Möller K; Bawahab AAA; Uhlig R; Huland H; Heinzer H; Graefen M; Schlomm T
Eur Urol; 2018 May; 73(5):674-683. PubMed ID: 28117112
[TBL] [Abstract][Full Text] [Related]
7. Prognostic influence of the third Gleason grade in prostatectomy specimens.
Cedeño Díaz OM; Fernández Aceñero MJ; Alvarez Fernández E
Urol Oncol; 2012; 30(4):386-90. PubMed ID: 21292510
[TBL] [Abstract][Full Text] [Related]
8. Metastatic potential to regional lymph nodes with Gleason score ≤7, including tertiary pattern 5, at radical prostatectomy.
Diolombi ML; Epstein JI
BJU Int; 2017 Jun; 119(6):872-878. PubMed ID: 27496532
[TBL] [Abstract][Full Text] [Related]
9. The effect of limited (tertiary) Gleason pattern 5 on the new prostate cancer grade groups.
Baras AS; Nelson JB; Han M; Parwani AV; Epstein JI
Hum Pathol; 2017 May; 63():27-32. PubMed ID: 27993581
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of tertiary Gleason pattern 5 in radical prostatectomy specimens.
Mosse CA; Magi-Galluzzi C; Tsuzuki T; Epstein JI
Am J Surg Pathol; 2004 Mar; 28(3):394-8. PubMed ID: 15104304
[TBL] [Abstract][Full Text] [Related]
11. Gleason score 5 + 3 = 8 (grade group 4) prostate cancer-a rare occurrence with contemporary grading.
Kryvenko ON; Williamson SR; Schwartz LE; Epstein JI
Hum Pathol; 2020 Mar; 97():40-51. PubMed ID: 31923450
[TBL] [Abstract][Full Text] [Related]
12. Presence of high grade tertiary Gleason pattern upgrades the Gleason sum score and is inversely associated with biochemical recurrence-free survival.
Turker P; Bas E; Bozkurt S; Günlüsoy B; Sezgin A; Postacı H; Turkeri L
Urol Oncol; 2013 Jan; 31(1):93-8. PubMed ID: 21316989
[TBL] [Abstract][Full Text] [Related]
13. Significance of Gleason Score 7 With Tertiary Pattern 5 at Radical Prostatectomy.
Borhan W; Epstein JI
Urology; 2017 Feb; 100():175-179. PubMed ID: 27810358
[TBL] [Abstract][Full Text] [Related]
14. Optimization of the 2014 Gleason grade grouping in a Canadian cohort of patients with localized prostate cancer.
Wissing M; Brimo F; Chevalier S; Scarlata E; McKercher G; O'Flaherty A; Aprikian S; Thibodeau V; Saad F; Carmel M; Lacombe L; Têtu B; Ekindi-Ndongo N; Latour M; Trudel D; Aprikian A
BJU Int; 2019 Apr; 123(4):624-631. PubMed ID: 30113732
[TBL] [Abstract][Full Text] [Related]
15. Re: Prognostic Significance of Percentage and Architectural Types of Contemporary Gleason Pattern 4 Prostate Cancer in Radical Prostatectomy.
Villers A; Rubin MA
Eur Urol; 2017 Feb; 71(2):301. PubMed ID: 27687819
[No Abstract] [Full Text] [Related]
16. Grading of Prostate Cancer: Past, Present, and Future.
Matoso A; Epstein JI
Curr Urol Rep; 2016 Mar; 17(3):25. PubMed ID: 26874537
[TBL] [Abstract][Full Text] [Related]
17. Gleason pattern 4 with cribriform morphology on biopsy is associated with adverse clinicopathological findings in a prospective radical prostatectomy cohort.
Haffner MC; Salles DC; Gao G; Epstein JI
Hum Pathol; 2020 Apr; 98():74-80. PubMed ID: 32119879
[TBL] [Abstract][Full Text] [Related]
18. Contemporary grading for prostate cancer: implications for patient care.
Brimo F; Montironi R; Egevad L; Erbersdobler A; Lin DW; Nelson JB; Rubin MA; van der Kwast T; Amin M; Epstein JI
Eur Urol; 2013 May; 63(5):892-901. PubMed ID: 23092544
[TBL] [Abstract][Full Text] [Related]
19. Impact of a tertiary Gleason pattern 4 or 5 on clinical failure and mortality after radical prostatectomy for clinically localised prostate cancer.
Servoll E; Saeter T; Vlatkovic L; Lund T; Nesland J; Waaler G; Axcrona K; Beisland HO
BJU Int; 2012 May; 109(10):1489-94. PubMed ID: 21933333
[TBL] [Abstract][Full Text] [Related]
20. Impact of Gleason pattern 5 including tertiary pattern 5 on outcomes of salvage treatment for biochemical recurrence in pT2-3N0M0 prostate cancer.
Taguchi S; Shiraishi K; Fukuhara H; Nakagawa K; Morikawa T; Naito A; Kakutani S; Takeshima Y; Miyazaki H; Nakagawa T; Fujimura T; Kume H; Homma Y
Int J Clin Oncol; 2016 Oct; 21(5):975-980. PubMed ID: 27098807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
